Kurt M Eichler - Net Worth and Insider Trading
Kurt M Eichler Net Worth
The estimated net worth of Kurt M Eichler is at least $5 Million dollars as of 2024-04-26. Kurt M Eichler is the Director of MiMedx Group Inc and owns about 574,576 shares of MiMedx Group Inc (MDXG) stock worth over $4 Million. Kurt M Eichler is the Director of Spring Bank Pharmaceuticals Inc and owns about 145,066 shares of Spring Bank Pharmaceuticals Inc (SBPH) stock worth over $702,119. Kurt M Eichler is also the Director of DARA Biosciences Inc and owns about 526,521 shares of DARA Biosciences Inc (DARA) stock worth over $463,338. Details can be seen in Kurt M Eichler's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Kurt M Eichler has not made any transactions after 2019-12-30 and currently still holds the listed stock(s).
Transaction Summary of Kurt M Eichler
Kurt M Eichler Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kurt M Eichler owns 4 companies in total, including Spring Bank Pharmaceuticals Inc (SBPH) , MiMedx Group Inc (MDXG) , and DARA Biosciences Inc (DARA) among others .
Click here to see the complete history of Kurt M Eichler’s form 4 insider trades.
Insider Ownership Summary of Kurt M Eichler
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SBPH | Spring Bank Pharmaceuticals Inc | 2020-06-24 | director |
| MDXG | MiMedx Group Inc | 2010-12-31 | director |
| DARA | DARA Biosciences Inc | 2008-02-12 | director |
| FSTX | F-star Therapeutics Inc | 2016-05-05 | director |
Kurt M Eichler Latest Holdings Summary
Kurt M Eichler currently owns a total of 3 stocks. Among these stocks, Kurt M Eichler owns 574,576 shares of MiMedx Group Inc (MDXG) as of December 31, 2010, with a value of $4 Million and a weighting of 75.56%. Kurt M Eichler owns 145,066 shares of Spring Bank Pharmaceuticals Inc (SBPH) as of December 30, 2019, with a value of $702,119 and a weighting of 14.73%. Kurt M Eichler also owns 526,521 shares of DARA Biosciences Inc (DARA) as of February 12, 2008, with a value of $463,338 and a weighting of 9.72%.
Latest Holdings of Kurt M Eichler
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MDXG | MiMedx Group Inc | 2010-12-31 | 574,576 | 6.27 | 3,602,592 |
| SBPH | Spring Bank Pharmaceuticals Inc | 2019-12-30 | 145,066 | 4.84 | 702,119 |
| DARA | DARA Biosciences Inc | 2008-02-12 | 526,521 | 0.88 | 463,338 |
Holding Weightings of Kurt M Eichler
Kurt M Eichler Form 4 Trading Tracker
According to the SEC Form 4 filings, Kurt M Eichler has made a total of 0 transactions in MiMedx Group Inc (MDXG) over the past 5 years. The most-recent trade in MiMedx Group Inc is the acquisition of 50,493 shares on December 31, 2010, which cost Kurt M Eichler around $49,988.
According to the SEC Form 4 filings, Kurt M Eichler has made a total of 1 transactions in Spring Bank Pharmaceuticals Inc (SBPH) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Spring Bank Pharmaceuticals Inc is the sale of 10,000 shares on December 30, 2019, which brought Kurt M Eichler around $50,400.
According to the SEC Form 4 filings, Kurt M Eichler has made a total of 0 transactions in DARA Biosciences Inc (DARA) over the past 5 years. The most-recent trade in DARA Biosciences Inc is the sale of 0 shares on February 12, 2008, which brought Kurt M Eichler around $0.
Insider Trading History of Kurt M Eichler
- 1
Kurt M Eichler Trading Performance
GuruFocus tracks the stock performance after each of Kurt M Eichler's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kurt M Eichler is -12.53%. GuruFocus also compares Kurt M Eichler's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kurt M Eichler within 3 months outperforms 2 times out of 10 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Kurt M Eichler's insider trading performs compared to the benchmark.
Performance of Kurt M Eichler
Average Return
21.73%
Outperforming Transactions
80%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -1.24 | -12.53 | -8.94 | 21.73 | 7.45 | -21.17 |
| Relative Return to S&P 500(%) | -2.28 | -16.41 | -17.41 | 7.58 | -5.82 | -32.59 |
Kurt M Eichler Ownership Network
Ownership Network List of Kurt M Eichler
Ownership Network Relation of Kurt M Eichler
Kurt M Eichler Owned Company Details
What does Spring Bank Pharmaceuticals Inc do?
Who are the key executives at Spring Bank Pharmaceuticals Inc?
Kurt M Eichler is the director of Spring Bank Pharmaceuticals Inc. Other key executives at Spring Bank Pharmaceuticals Inc include VP of Finance and Treasurer Lori Firmani , director & President and CEO Martin J Driscoll , and Chief Scientific Officer Radhakrishnan P. Iyer .
Spring Bank Pharmaceuticals Inc (SBPH) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Spring Bank Pharmaceuticals Inc (SBPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Spring Bank Pharmaceuticals Inc (SBPH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Spring Bank Pharmaceuticals Inc (SBPH)'s detailed insider trading history can be found in Insider Trading Tracker table.
Spring Bank Pharmaceuticals Inc Insider Transactions
Kurt M Eichler Mailing Address
Above is the net worth, insider trading, and ownership report for Kurt M Eichler. You might contact Kurt M Eichler via mailing address: C/o Spring Bank Pharmaceuticals, Inc., Ste S-7, Milford Ma 01757.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
